Rep. Josh Gottheimer Buys U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

Representative Josh Gottheimer (D-New Jersey) recently bought shares of U.S. Physical Therapy, Inc. NYSE: USPH. In a filing disclosed on November 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in U.S. Physical Therapy stock on October 17th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Texas Capital Bancshares NASDAQ: TCBI on 10/31/2024.
• Sold $1,001 - $15,000 in shares of ITT NYSE: ITT on 10/31/2024.
• Sold $1,001 - $15,000 in shares of Stifel Financial NYSE: SF on 10/31/2024.
• Sold $1,001 - $15,000 in shares of ICU Medical NASDAQ: ICUI on 10/31/2024.
• Sold $1,001 - $15,000 in shares of AppFolio NASDAQ: APPF on 10/31/2024.
• Purchased $1,001 - $15,000 in shares of Gates Industrial NYSE: GTES on 10/31/2024.
• Purchased $1,001 - $15,000 in shares of Techtronic Industries OTCMKTS: TTNDY on 10/29/2024.
• Purchased $1,001 - $15,000 in shares of Techtronic Industries OTCMKTS: TTNDY on 10/28/2024.
• Purchased $1,001 - $15,000 in shares of Disco OTCMKTS: DSCSY on 10/28/2024.
• Purchased $1,001 - $15,000 in shares of Enerpac Tool Group NYSE: EPAC on 10/25/2024.

U.S. Physical Therapy Trading Down 0.1 %

Shares of USPH stock traded down $0.11 during trading hours on Friday, hitting $95.16. 112,252 shares of the company were exchanged, compared to its average volume of 91,536. The firm has a fifty day moving average of $83.43 and a 200 day moving average of $91.56. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The firm has a market cap of $1.44 billion, a PE ratio of 101.70, a PEG ratio of 4.67 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.76 EPS. Analysts expect that U.S. Physical Therapy, Inc. will post 2.54 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.85%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is 187.23%.

Analysts Set New Price Targets

A number of research firms recently commented on USPH. Barrington Research reiterated an "outperform" rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday. StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Finally, Bank of America reiterated a "neutral" rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of the business. Canada Pension Plan Investment Board bought a new position in U.S. Physical Therapy during the 2nd quarter worth $28,000. Innealta Capital LLC bought a new position in shares of U.S. Physical Therapy during the second quarter worth about $30,000. Quest Partners LLC grew its position in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company's stock worth $32,000 after acquiring an additional 337 shares during the last quarter. Quarry LP increased its holdings in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company's stock worth $48,000 after acquiring an additional 478 shares during the period. Finally, Ridgewood Investments LLC bought a new stake in U.S. Physical Therapy in the 2nd quarter valued at about $51,000.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the acquisition, the director now directly owns 18,904 shares of the company's stock, valued at $1,627,445.36. This represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company's stock, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by company insiders.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer's career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer's committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.